Thomas Blankenstein

Overview

Best Publications

• CCR7 Governs Skin Dendritic Cell Migration under Inflammatory and Steady-State Conditions

  Lars Ohl;Mariette Mohaupt;Niklas Czeloth;Gabriele Hintzen

  1472
  Citations

• CD4+ T Cell–Mediated Tumor Rejection Involves Inhibition of Angiogenesis that Is Dependent on IFNγ Receptor Expression by Nonhematopoietic Cells

  Zhihai Qin;Thomas Blankenstein

  791
  Citations

• Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance

  Gerald Willimsky;Thomas Blankenstein;Thomas Blankenstein

  627
  Citations

• B cells inhibit induction of T cell-dependent tumor immunity.

  Zhihai Qin;Günther Richter;Thomas Schüler;Sabrina Ibe

  537
  Citations

• The determinants of tumour immunogenicity.

  Thomas Blankenstein;Thomas Blankenstein;Pierre G. Coulie;Eli Gilboa;Elizabeth M. Jaffee

  512
  Citations

• Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

  Brocke S;Gijbels K;Allegretta M;Ferber I

  433
  Citations

• Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.

  Thomas Blankenstein;Zheng Hong Qin;K Uberla;Werner Muller

  413
  Citations

• A Critical Requirement of Interferon γ-mediated Angiostasis for Tumor Rejection by CD8+ T Cells

  Zhihai Qin;Johannes Schwartzkopff;Felicia Pradera;Thomas Kammertoens

  354
  Citations

• Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

  H Hock;M Dorsch;T Diamantstein;T Blankenstein

  352
  Citations

• CD4-Positive T Lymphocytes Provide a Neuroimmunological Link in the Control of Adult Hippocampal Neurogenesis

  Susanne A. Wolf;Susanne A. Wolf;Susanne A. Wolf;Barbara Steiner;Barbara Steiner;Akgul Akpinarli;Thomas Kammertoens;Thomas Kammertoens

  342
  Citations

• Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma

  Hanno Hock;Marion Dorsch;Ulrich Kunzendorf;Zhihai Qin

  322
  Citations

• Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.

  Barbara Seliger;Ursula Wollscheid;Frank Momburg;Thomas Blankenstein

  290
  Citations

• Retroviral Vectors for High-Level Transgene Expression in T Lymphocytes

  Boris Engels;Hakan Cam;Thomas Schüler;Stefano Indraccolo

  287
  Citations

• Tumour ischaemia by interferon-γ resembles physiological blood vessel regression

  Thomas Kammertoens;Christian Friese;Christian Friese;Ainhoa Arina;Christian Idel

  279
  Citations

• Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells.

  Z Qin;G Noffz;M Mohaupt;T Blankenstein

  273
  Citations

• Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.

  Alessandra Allione;Manuela Consalvo;Patrizia Nanni;Pier Luigi Lollini

  254
  Citations

• The role of tumor stroma in the interaction between tumor and immune system.

  Thomas Blankenstein

  252
  Citations

• Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

  Anna Kruschinski;Andreas Moosmann;Isabel Poschke;Håkan Norell

  251
  Citations

• Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13.

  Natacha Bessis;Marie-Christophe Boissier;Pascual Ferrara;Thomas Blankenstein

  248
  Citations

• T Helper Cell Type 1–associated and Cytotoxic T Lymphocyte–mediated Tumor Immunity Is Impaired in Interleukin 4–deficient Mice

  Thomas Schüler;Zhihai Qin;Sabrina Ibe;Nancy Noben-Trauth

  233
  Citations